Trial intelligence / Profile preview

Prevention of Infections in Cardiac Surgery (PICS)

NCT06567808Phase 4Not yet recruiting

Sponsor
Hamilton Health Sciences
Start
Mar 2026
Primary completion
Apr 2028
Modality
Reversible Covalent Inhibitors, Cyclic Peptides, Antimicrobial Peptides
01

Overview

A Phase 4 trial of vancomycin, cefazolin in surgical site infection (SSI), sponsored by Hamilton Health Sciences. Planned start Mar 2026; status: not yet recruiting.

02

Drugs

vancomycincefazolin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT06567808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06567808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call